Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Net Income

Net Income at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$92.53M+37.0%
ALN
Alnylam PharmaceuticalsALNY
$205.99M+1,229%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$122.93M+9.6%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$94.32M+12.9%
Immunome logo
ImmunomeIMNM
-$53.84M-29.3%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$44.9M+11.7%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.13B+106%
Enterprise value$2.08B+100%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's net income?
Intellia Therapeutics (NTLA) reported net income of -$96.23M in Q1 2026.
How has Intellia Therapeutics's net income changed year-over-year?
Intellia Therapeutics's net income increased by 15.8% year-over-year, from -$114.33M to -$96.23M.
What is the long-term trend for Intellia Therapeutics's net income?
Over 4 years (2021 to 2025), Intellia Therapeutics's net income has grown at a 11.4% compound annual growth rate (CAGR), from -$267.89M to -$412.69M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.